268 results on '"Westermann F"'
Search Results
2. China's capital flight: Pre- and post-crisis experiences
3. Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma
4. Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma
5. A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
6. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance
7. Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma
8. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
9. Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
10. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma
11. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
12. ALK Mutations in Primary and Relapsed Neuroblastoma in a GPOH Cohort
13. Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients
14. A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma
15. The Seniority Conundrum – Further Evidence
16. PO-461 Mitochondria-mediated anticancer effect of diphenyleneiodonium chloride (DPI) in aggressive neuroblastoma is regulated by MYCN
17. Flubendazole as potential anti-neuroblastoma therapy option
18. Integrated Genomic Analysis Identifies Specific Alterations and Activation of Yap in Relapsed Neuroblastoma
19. Telomerase activation by genomic rearrangements in high-risk neuroblastoma
20. Mutational dynamics between primary and relapse neuroblastoma involve genes relevant for mesenchymal transition
21. Mutational dynamics between primary and relapse neuroblastomas
22. MYCN TRANSCRIPTIONALLY REPRESSES CD9 TO TRIGGER AN INVASION-METASTASIS CASCADE IN NEUROBLASTOMA
23. INTEGRATED GENOMIC ANALYSIS IDENTIFIES SPECIFIC ALTERATIONS AND ACTIVATION OF YAP IN RELAPSED NEUROBLASTOMA
24. TELOMERASE ACTIVATION BY RECURRENT GENOMIC REARRANGEMENTS IN HIGH-RISK NEUROBLASTOMA
25. DEVELOPMENT OF A SCORING SYSTEM BASED ON A PROGNOSTIC INDEX FOR RISK ASSESSMENT OF PATIENTS WITH NEUROBLASTOMA
26. Building a synchronous common-cycle index for the European Union
27. Das Fabry-Pérot-Interferometer im Mikrowellengebiet: II. Eine Diskussion unter Berücksichtigung von Beugungseffekten
28. Das Fabry-Perot-Interferometer im Mikrowellengebiet: I. Eine Diskussion unter den Voraussetzungen der Optik (Annahme vernachlässigbarer Beugungseffekte)
29. Transcription factor activating protein 2 beta (TFAP2B) mediates neuronal differentiation in neuroblastoma
30. REVISED RISK ESTIMATION AND TREATMENT STRATIFICATION OF LOW- AND INTERMEDIATE-RISK NEUROBLASTOMA PATIENTS BY INTEGRATING CLINICAL AND MOLECULAR PROGNOSTIC MARKERS
31. 409 Transcription factor activating protein 2 beta (TFAP2B) mediates neuronal differentiation in neuroblastoma
32. Heterogeneity of the MYCN oncogene in neuroblastoma
33. Deformation of Tungsten Carbide Tools when Cutting Inconel 718
34. Korte Samenvatting van de in Deze Aflevering Opgenomen Artikelen
35. Korte Samenvattingen van de in Deze Aflevering Opgenomen Artikelen
36. Boekbeoordelingen
37. Brandpreventie
38. De Subrogatie en de Brandverzekeraar
39. A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
40. 126 - Flubendazole as potential anti-neuroblastoma therapy option
41. 553 - Flubendazole as potential anti-neuroblastoma therapy option
42. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
43. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance
44. Development of an IL-21 enhanced MYCN-DNA vaccine for anti-neuroblastoma immunotherapy
45. Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma
46. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival
47. MYCN/MYC-mediated drug resistance mechanisms in neuroblastoma
48. Gene expression-based classification improves risk estimation of neuroblastoma patients
49. The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines
50. The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.